UNI MEDICAL (02666) intends to issue corporate bonds with a total principal amount not exceeding 1 billion RMB.
Global Medical (02666) announces that its wholly-owned subsidiary, Global Leasing Co., Ltd., has obtained...
UNI MEDICAL (02666) announcement that its wholly-owned subsidiary, China Global Leasing Co., Ltd., has received approval from the China Securities Regulatory Commission to publicly issue up to RMB 8 billion of domestic corporate bonds for qualified investors in the People's Republic of China. As of the date of this announcement, the remaining amount of the bond is RMB 7.5 billion. The bonds will be issued in multiple tranches, with the issuer's first tranche of bonds in 2025 not exceeding RMB 1 billion, with a base term of five years and options for the issuer to redeem, adjust interest rates, and for investors to sell back their bonds at the end of the third year.
Related Articles

New stock preview | Financial mirror fracture: decoding the growth logic paradox behind the Shanghai Jizhi "smart manufacturing" narrative.

New Stock Update | Wuxi Lead Intelligent Equipment (300450.SZ) held a hearing at the Hong Kong Stock Exchange, claiming to be the second largest supplier of new energy intelligent equipment in the world with a market share of 2.9%.

New Stock News | CanuBio submits application to Hong Kong Stock Exchange
New stock preview | Financial mirror fracture: decoding the growth logic paradox behind the Shanghai Jizhi "smart manufacturing" narrative.

New Stock Update | Wuxi Lead Intelligent Equipment (300450.SZ) held a hearing at the Hong Kong Stock Exchange, claiming to be the second largest supplier of new energy intelligent equipment in the world with a market share of 2.9%.

New Stock News | CanuBio submits application to Hong Kong Stock Exchange

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


